top of page
Executive Spotlights

Thermo Fisher Scientific to buy Olink in $3.1B deal

Waltham, MA, October 17, 2023 (Reuters) -- Thermo Fisher Scientific (TMO.N) announced plans to purchase Olink Holding AB (OLK.O) for $3.1 billion. This acquisition bolsters the U.S. medical equipment company's life sciences portfolio, specifically in the field of drug discovery.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial


Life Science Headlines
bottom of page